SGRX — Sangrix Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.13 | ||
| Price to Tang. Book | 0.13 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -72.48% | ||
| Return on Equity | -348.73% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 30th Jun | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.19 | 6.26 | 2.89 | 0.04 | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
SANGRIX INC., formerly Bit Origin Ltd, is a Singapore-based company focused on artificial intelligence (AI) computing infrastructure and related digital infrastructure opportunities. The Company is evaluating and pursuing opportunities involving graphics processing unit (GPU) computing, server leasing, storage infrastructure and related services. The Company is also managing its digital assets and legacy operations.
Directors
- Last Annual
- June 30th, 2026
- Last Interim
- June 30th, 2026
- Incorporated
- January 23rd, 2018
- Public Since
- August 14th, 2019
- No. of Employees
- 1
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 1,895,731
- Address
- 160 Robinson Road, 12F, SBF Ce, 068914
- Web
- https://bitorigin.io
- Phone
- +1 3475564747
- Auditors
- HTL International LLC
Latest News for SGRX
Upcoming Events for SGRX
Full Year 2026 Bit Origin Ltd Earnings Release
Similar to SGRX
22nd Century
NASDAQ Capital Market
Air Global
NASDAQ Capital Market
Aquabounty Technologies
NASDAQ Capital Market
Arcadia Biosciences
NASDAQ Capital Market
Australian Oilseeds Holdings
NASDAQ Capital Market
FAQ
As of Today at 05:07 UTC, shares in Sangrix are trading at $0.69. This share price information is delayed by 15 minutes.
Shares in Sangrix last closed at $0.69 and the price had moved by -99.45% over the past 365 days. In terms of relative price strength the Sangrix share price has underperformed the S&P500 Index by -99.53% over the past year.
There is no consensus recommendation for this security.
Find out moreSangrix does not currently pay a dividend.
Sangrix does not currently pay a dividend.
Sangrix does not currently pay a dividend.
To buy shares in Sangrix you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.69, shares in Sangrix had a market capitalisation of $1.30m.
Here are the trading details for Sangrix:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: SGRX
Based on an overall assessment of its quality, value and momentum Sangrix is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sangrix. Over the past six months, its share price has underperformed the S&P500 Index by -94.71%.
As of the last closing price of $0.69, shares in Sangrix were trading -93.94% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Sangrix PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.69.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Sangrix's directors